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1. Introduction 
The first component of complement, Cl, is a Ca*+- 
dependent complex of 3 subunits, Clq, Clr and Cls 
[ 11. When Cl binds to immune complexes via Cl q, a 
single chain zymogen Clr is proteolytically activated 
into two-chain Cli, which subsequently catalyzes a 
proteolytic activation of Cls [2]. Since the activation 
of Clr is a triggering reaction for the sequential acti- 
vation of the classical pathway of complement, how 
Clr becomes activated upon binding of Cl to immune 
complexes has been of interest. 
Although there remain inconsistencies about details 
of the activation mechanism, the activation of Cl r has 
been accepted to be an autocatalytic reaction [3-61 
and the proteolytic site for autoactivation of Clr has 
been proposed to be generated in a zymogen Clr 
through a conformational change [4,5]. However, no 
report directly indicates that a conformational change 
occurs in a zymogen Clr prior to the proteolytic acti- 
vation of Clr. 
Here, we examined a possible conformational 
change occurring during the autoactivation of isolated 
Clr, using a hydrophobic fluorescent probe, 7-@ 
methoxybenzylamino)+nitrobenzoxadiazole (MBD), 
which is strongly fluorescent upon binding to a hydro- 
Abbreviations: MBD, 7-@-methoxybenzylamino)-4-nitroben- 
zoxadiazole; NPGB, p-nitrophenyl-p’guanidinobenzoate; 
DFP, diisopropylfluorophosphate; SDS-PAGE, sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis; TLC, 
thin-layer chromatography;Mr, relative molecular mass 
Nomenclature: Components of complement follow that 
recommended by the World Health Organization (1968); a 
bar indicates the activated state of a component 
phobic area of a macromolecule [7]. We show that 
upon incubation of isolated Clr at 37’C, a conforma- 
tional change, as judged by the MBD binding assay, 
occurs rapidly and reversibly and after a time lag, a 
progressive limited proteolysis occurs to produce an 
active Cli. The implication of the present results for 
autocatalytic activation of Clr is discussed. 
2. Experimental 
2.1. Complement components 
Clr was purified from human serum as follows: 
300 ml human serum, containing 1 mM diisopropyl- 
fluorophosphate (DFP, Kishida Chemicals) and 
0.5 mM p-nitrophenyl-p’-guanidinobenzoate (NPGB, 
United States Biochemical Corp.) and 200 ml IgG- 
Sepharose (10 mg IgG/ml Sepharose 6B, Pharmacia, 
Uppsala) pre-equilibrated with 2.5 mM veronal buffer 
(pH 7.4) containing 0.15 M NaCl and 1 mM CaC12 
were mixed under stirring for 60 min at 0°C. The 
IgG-Sepharose layer was poured on a filter funnel 
and quickly washed with 6 1 starting buffer at 0°C. 
The washed IgG-Sepharose was then packed into a 
column (4 X 17 cm) and eluted with 0.2 M diamino- 
butane (pH 7.4) containing 0.15 M NaCl. Clr fraction 
thus eluted was mixed with 2 M DFP to give 1 mM 
final cont. and dialyzed against 20 mM phosphate 
buffer (pH 7.4) containing 10 mM EDTA and 0.5 mM 
NPGB. The dialyzed Clr fraction was applied to a 
column (1.5 X 4.0 cm) of DE-52 (Whatman), pre- 
equilibrated with 20 mM phosphate buffer (pH 7.4) 
containing 10 mM EDTA and eluted by a linear 
increase of [NaCl] from O-O.25 M with a total 200 ml 
of the starting buffer. Clr fraction thus obtained was 
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concentrated and finally purified by gel filtration 
through a column (2.5 X 60 cm) of Sephadex G-200 
in 50 mM acetate buffer (pH 5.5) containing 0.1 M 
NaCl and 10 mM EDTA. About 1.5 mg purified Clr 
was obtained by these procedures and kept at 0°C 
before use. For detection of Clr fractions, lo-50 ~1 
of each fraction and 5-10 lug Cls were incubated for 
30 min at 37°C and the esterase activity of ClS thus 
activated was determined with 5 mM acetyl-glycyl- 
lysine methyl ester (Peptide Institute, Japan) as a sub- 
strate [8]. Cli and Cls were purified from human 
plasmaaccording to [8] and [9], respectively. Reduced 
Clr showed a single band of 100 OOOM, upon SDS- 
PAGE, while reduced Clr showed two bands of 
60 000 and 40 000 MI upon SDS-PAGE (fig.1). 
2.2. Fluorescent measurement 
Measurements of binding of MBD (Dojin Labs, 
Japan) to Clr and Cli were made at -4Opgprotein/ml. 
Binding experiments were conducted at 20°C and 
pH 7.4, utilizing a 20 mM Tris-HCl buffer, containing 
4 PM MBD and 0.15 M NaCl. Fluorescent emission 
spectra were recorded in a Hitachi fluorescent pho- 
tometer over 500-600 nm under excitation at 
490 nm. 
Fig.1. SDS -PAGE of Clr and Cl?: Clr and Cli were reduced 
and subjected to SDS-PAGE according to [lo]. 
2.3. SDS-PAGE 
Electrophoresis was done in 5.6% polyacrylamide 
gel in buffer containing 0.1% SDS as in [lo]. The 
applied proteins were heated for 5 mm at 100°C with 
1% SDS and 2% 2-mercaptoethanol. The gels were 
stained with Coomassie blue R-250 and scanned using 
a dual-wavelength TLC scanner. 
3. Results 
3.1. Binding of MBD to Clr and Cli 
Fig.2 shows the fluorescent spectra of free MBD, 
MBD-Clr, andMBD-ClI solutions. Free MBD shows 
the maximum fluorescent emission at 560 nm when- 
excited at 490 nm. When Clr was added to MBD, 
there was a marked increase in fluorescent intensity 
with a corresponding decrease in wavelength of maxi- 
mum emission of -20 nm, suggesting binding of MBD 
to a hydrophobic area of Clr. On the contrary, addi- 
tion of Cli to MBD did not induce any significant 
change in the fluorescent spectrum of MBD, suggesting 
that the MBD-binding hydrophobic area in a zymogen 
Clr is disrupted upon proteolytic activation of Clr. 
3.2. Relationship between a conformational change 
and proteolytic activation of Clr 
The above results uggested that MBD was a useful 
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Fig.2. Fluorescent emission spectra of MBD, MBD-Clr and 
MBD-Clf solutions: (- - - -) MBD (4 NM) alone; (-) MBD- 
Clr; (- - -) MBD-C1. Excitation was at 490 nm. Clr and 
Clf were 40pg protein/ml in 20 mM Tris-HCl buffer (pH 7.4). 
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Incubation Timetmin) 
Fig.3. Time courses of a conformational change and proteoly- 
tic activation of Clr upon incubation at 37°C. Clr (40 pg/ml) 
was incubated for different periods at 37°C and determined 
for conformational change (o-e) by MBD-binding assay 
and proteolytic activation (o-o) by SDS-PAGE after 
reduction. The fluorescent data are expressed as % fluorescent 
intensity which was calculated by assuming that the fluores- 
cent intensities of MBD-Clr and MBD alone are 100% and 
0%, respectively; % Activation of Clr was determined by 
SDS-PAGE after reduction and scanning the gels after stain- 
ing with Coomassie blue. The reversibility of a conformational 
change of Clr (e---o) was determined by measuring the 
recovery of MBD-binding activity after chilling the incubated 
Clr in ice bath, as described in the text. 
tool for analysis of a possible conformational change 
occurring during autoactivation of Clr. Then, we 
attempted to follow autoactivation of Clr both by 
measuring the limited proteolysis and a conforma- 
tional change of Clr by SDS-PAGE and the MBD- 
binding assay, respectively. 
The cleavage of Clr into twochain Cli proceeded 
showing a sigmoidal curve with a lag phase of -10 min, 
suggesting an autocatalytic process (tig.3). However, 
the MBD-binding assay revealed that a conformational 
change rapidly occurred without any lag phase and 
reached its plateau during the first 10 min of incuba- 
tion at 37°C. These results suggest hat autoactivation 
of Clr is a two-step reaction; the first rapid confor- 
mational change and the subsequent slow limited 
proteolysis of an altered Clr. 
Neither conformational change nor limited prote- 
olysis of Clr occurred when autoactivation of Clr 
was attempted at 20°C suggesting that the conforma- 
tional change of Clr is a reaction of thermal depen- 
dency, as proposed in [.5]. Then it was interesting 
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whether the conformational change of Cl r is a revers- 
ible or irreversible reaction. To make clear this prob- 
lem, Clr pre-incubated for different periods at 37’C, 
was chilled at 0°C and measured for the recovery of 
MBD-binding ability. Fig.3 (---) shows that if the 
incubation period of Clr at 37°C is <lO min (i.e., 
during the lag phase of autoactivation) the disrupted 
hydrophobic area of Clr appears to be fully refolded 
upon chilling at 0°C. However, as the proteolytic acti- 
vation of Clr progressed, there was an approximately 
proportional decrease in the refolding of MBD-binding 
area. These results suggest hat the conformational 
change to produce altered Clr is a reversible reaction 
and that once altered, Clr is cleaved into two-chain 
Cl i, the MBD-binding hydrophobic area is not refolded 
even chilling at 0°C. 
4. Discussion 
Using MBD as a hydrophobic probe, it is now pos- 
sible to detect a conformational change of Clr which 
occurs prior to the autocatalytic cleavage of Clr. 
Considering that the conformational change of Cl r is 
induced at 37°C but not at 20°C and is reversed upon 
chilling at 0°C a high energy seems to be required 
both for initiation of a conformational change and 
holding the resulting excited conformation of a 
zymogen Clr. MBD was first used for analysis of a 
conformational change occurring during autoactiva- 
tion of trypsinogen [7]. A hydrophobic area able to 
bind MBD was present in trypsinogen and disrupted 
proportionately with activation into trypsin. Under 
the condition that Clr binds MBD, neither Cls nor 
Cl S binds MBD (not shown), suggesting that although 
Clr and Cls are similar inM,, ammo acid composi- 
tion and partial amino acid sequence [2], the two 
homologous zymogens differ characteristically in a 
conformation which is responsible for the MBD- 
binding hydrophobic area. We found that autoactiva- 
tion of Clr proceeded in the presence of MBD (not 
shown). This result suggests that the MBD-binding 
hydrophobic area has no relation to the potential 
catalytic site for autoactivation of Clr. 
Several authors reported that the autoactivation of 
Clr was catalyzed not by activated Cli but by an 
active site possibly generated in a zymogen Clr [4,5]. 
The intermediary Clr having an autocatalytic site was 
termed Clr*, which was proposed to be reversibly 
inhibited by NPGB [4]. The catalytic site in Clr* was 
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supposed to be generated by a conformational change 
which is slow and gives rise to the time lag in the 
autoactivation of Clr [4]. MBD-binding assay revealed 
that a conformational change of Cl r rapidly occurred 
upon incubation at 37’C, while the proteolytic acti- 
vation of Clr proceeded after a time lag for 10 min. 
So, it seems unlikely that the putative Clr* is gener- 
ated in parallel to the rapid conformational change of 
Clr. It may be that following the rapid conforma- 
tional change of Clr, a slow conformational change 
subsequently occurs and produces the putative Cl r* 
capable of activating Clr. An alternative possibility is 
that a proteolytic site is rapidly generated in parallel 
to the conformational change of Clr but catalyzes 
only slowly the activation of altered Clr into active 
Cl;, which once formed, catalyzes rapidly proteolytic 
activation of altered Clr. Although this mechanism 
may well explain the kinetics of autoactivation of Clr, 
there are several reports suggesting that Clf by itself 
has no ability to activate Clr [4,5]. However, it was 
reported in an abstract [1 l] that autoactivation of
Clr involveda double mechanism: the first intramolec- 
ular catalysis due to Clr itself; the second intermolec- 
ular reaction due to activated ClI itself. 
Further studies, such as active site titration with 
NPGB or conformational nalysis with different kinds 
of fluorescent hydrophobic probes will be required to 
more clearly define which mechanism isresponsible 
for the autoactivation of Clr. 
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